Occupe actuellement des postes chez Revance Therapeutics Inc, SI-BONE Inc, ZELTIQ Aesthetics Inc and Revance Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | Revance Therapeutics Inc | 5 septembre 2017 - |
Independent Director | SI-BONE Inc | 17 juin 2019 - |
President, Chief Executive Officer | ZELTIQ Aesthetics Inc | 28 avril 2017 - |
President, Chief Executive Officer, Director | Revance Therapeutics Inc | 13 octobre 2019 - |
Independent Director | Revance Therapeutics Inc | 5 septembre 2017 - 13 octobre 2019 |
Chairman of the Board, President, Chief Executive Officer | ZELTIQ Aesthetics Inc | 1 janvier 2015 - 28 avril 2017 |
President, Chief Executive Officer, Director | ZELTIQ Aesthetics Inc | 19 novembre 2012 - 1 janvier 2015 |
President, Chief Executive Officer, Interim Chief Financial Officer, Director | ZELTIQ Aesthetics Inc | 23 août 2012 - 19 novembre 2012 |
Interim President, Chief Executive Officer, Interim Chief Financial Officer, Director | ZELTIQ Aesthetics Inc | 9 août 2012 - 23 août 2012 |
Interim President and Chief Executive Officer, Director | ZELTIQ Aesthetics Inc | 19 avril 2012 - 9 août 2012 |
Director | ZELTIQ Aesthetics Inc | 1 mai 2010 - 19 avril 2012 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-08 | 2024-03-06 |
Revance Therapeutics Inc
(RVNC)
|
A Achat |
30 000
+3.0%
6,98209 400 USD |
30 000 +3.0% | 6,98 | 209 400 USD | |
2024-02-26 | 2024-02-23 |
Glaukos Corp
(GKOS)
|
V Vente |
4 560
-12.1%
92,87423 487 USD |
4 560 -12.1% | 92,87 | 423 487 USD | |
2023-08-04 | 2023-08-03 |
Revance Therapeutics Inc
(RVNC)
|
VP Vente planifiée |
26 279
-3.0%
22,57593 151 USD |
26 279 -3.0% | 22,57 | 593 151 USD | |
2023-07-05 | 2023-07-03 |
Revance Therapeutics Inc
(RVNC)
|
VP Vente planifiée |
26 279
-2.9%
24,94655 333 USD |
26 279 -2.9% | 24,94 | 655 333 USD | |
2023-06-13 | 2023-06-09 |
Revance Therapeutics Inc
(RVNC)
|
VP Vente planifiée |
31 279
-3.4%
30,72960 928 USD |
31 279 -3.4% | 30,72 | 960 928 USD | |
2023-05-16 | 2023-05-15 |
Revance Therapeutics Inc
(RVNC)
|
V Vente |
70 447
-7.1%
34,552 433 725 USD |
70 447 -7.1% | 34,55 | 2 433 725 USD | |
2021-11-29 | 2021-11-29 |
Revance Therapeutics Inc
(RVNC)
|
A Achat |
40 000
+56.4%
12,90515 924 USD |
40 000 +56.4% | 12,90 | 515 924 USD | |
2016-03-23 | 2016-03-22 |
ZELTIQ Aesthetics Inc
(ZLTQ)
|
VP Vente planifiée |
9 698
-2.6%
25,01242 568 USD |
9 698 -2.6% | 25,01 | 242 568 USD | |
2016-03-22 | 2016-03-18 |
ZELTIQ Aesthetics Inc
(ZLTQ)
|
VP Vente planifiée |
1 272
-0.3%
25,0131 816 USD |
1 272 -0.3% | 25,01 | 31 816 USD |